Let’s start up with the current stock price of AcelRx Pharmaceuticals Inc. (ACRX), which is $1.31 to be very precise. The Stock rose vividly during the last session to $1.41 after opening rate of $1.24 while the lowest price it went was recorded $1.23 before closing at $1.23.
Recently in News on December 10, 2020, AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA®. AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication by the Journal of Universal Surgery of clinical data on the use of DSUVIA for acute perioperative pain management. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
AcelRx Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.1400 on 01/02/20, with the lowest value was $0.7014 for the same time period, recorded on 03/23/20.
AcelRx Pharmaceuticals Inc. (ACRX) full year performance was -42.54%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AcelRx Pharmaceuticals Inc. shares are logging -46.31% during the 52-week period from high price, and 86.77% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.70 and $2.44.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2794718 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the AcelRx Pharmaceuticals Inc. (ACRX) recorded performance in the market was -37.91%, having the revenues showcasing -12.08% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 130.48M, as it employees total of 25 workers.
Analysts verdict on AcelRx Pharmaceuticals Inc. (ACRX)
During the last month, 0 analysts gave the AcelRx Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.4531, with a change in the price was noted +0.1900. In a similar fashion, AcelRx Pharmaceuticals Inc. posted a movement of +16.96% for the period of last 100 days, recording 1,553,988 in trading volumes.
AcelRx Pharmaceuticals Inc. (ACRX): Technical Analysis
Raw Stochastic average of AcelRx Pharmaceuticals Inc. in the period of last 50 days is set at 12.82%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 27.78%. In the last 20 days, the company’s Stochastic %K was 14.81% and its Stochastic %D was recorded 9.41%.
Let’s take a glance in the erstwhile performances of AcelRx Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -37.91%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -1.50%, alongside a downfall of -42.54% for the period of the last 12 months. The shares increased approximately by 2.34% in the 7-day charts and went up by -10.27% in the period of the last 30 days. Common stock shares were lifted by -12.08% during last recorded quarter.